able cerebral
Able Cerebral is currently apply phase III clinical study with FDA for its controlled release of brain energy product. The product has shown remarkable therapeutic effectiveness for mid-stage and early stage Alzheimer's disease.
Able Cerebral is also developing a game changing, non-invasive medical device that will consolidate and recovery of brain memory for mid-stage and late stage Alzheimer's disease.
jun xia
Co-Founder / PresidentConsulate General of Canada in Shanghai
Lulu Mi
Life Sciences Trade CommissionerIHM-GBA
Based in Guanghzou, China, IHM-GBA is an innovation center focusing on high performance medical device. We are seeking global opportunities of bringing disruptive technologies to the Chinese market. We invest in and partner with startups that are interested in exploring China and use our resources to commercialize their products.
Mr shu zeng
DirectorMedWorld Advisors
Dave Sheppard
Managing DirectorOlympus
Felicia Chung
APAC Region Business Development LeadPhysioCue

Tractivus SL
PHOBOSTech™ technology have been developed over the years in Tractivus SL as a solution to the current problems of medical devices. Our cost-effective patented technology allows to create nanostructures on the surface, preventing bacteria attachment and, therefore, bacteria colonization. As a result our devices show higher lifetime, lower associated costs, and no post-implantation problems without adverse effect on the patients.
Tractivus SL combines the experience of the research groups and a unique solution designed to root out the colonization of the devices through a micro- and nano-structured coating that protects the device from adhesion and bacterial colonization. The team has worked on all aspects of the development: material selection, regulatory strategy, risk reduction, clinical trials, partners, stakeholders... aiming to maximize the success of both the project and the investors.
